Release Date: 31/01/14 16:26 Summary: Quarterly Report December 2013 Price Sensitive: Yes Download Document 1.63MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%